Back to search

Belgium· BE-AMP-SAM501386-00

Colowash 1102 mg - 398 mg

A osmotically acting laxatives product containing sodium dihydrogen phosphate monohydrate, registered in Belgium by Laboratoires Mayoly Spindler. The same ATC class is registered in 6 of our 19 countries.

ATC A06AD

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedColowash 1102 mg - 398 mgATCA06ADREGISTER NO.BE-AMP-SAM501386-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Sodium dihydrogen phosphate monohydrate is registered in 6 of 19 countries.

Countries holding a registration under ATC A06AD (osmotically acting laxatives), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose

Sodium dihydrogen phosphate monohydrate · ATC A06AD

6 / 19 countries

  • Belgiumprice
  • Denmark
  • Ireland
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Sodium Dihydrogen Phosphate Monohydrate
Manufacturer
Laboratoires Mayoly Spindler
Country
Belgium (BE)
ATC code
A06AD
ATC class
Osmotically acting laxatives
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    3915931

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Sodium dihydrogen phosphate monohydrate in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sodium dihydrogen phosphate monohydrate products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Spain · Fosfato

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/119aa4f1-0468-4cdf-bd98-c21371bfee33
GET /v1/drugs/119aa4f1-0468-4cdf-bd98-c21371bfee33?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Colowash 1102 mg - 398 mg",
  "name_fr": "Colowash 1102 mg - 398 mg",
  "name_nl": "Colowash 1102 mg - 398 mg",
  "amp_code": "SAM501386-00",
  "strengths": [
    "1102.0000",
    "398.0000",
    "398.0000",
    "1102.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Sodium Dihydrogen Phosphate Monohydrate",
    "Sodium Dihydrogen Phosphate Anhydrous"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Osmotically Acting Laxatives",
  "authorisation_numbers": [
    "BE501386"
  ]
}

See everything about sodium dihydrogen phosphate monohydrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.